bf/NYSE:CE_icon.jpeg

COM:CELANESE

Celanese Corporation

  • Stock

USD

Last Close

75.00

22/11 21:00

Market Cap

14.71B

Beta: -

Volume Today

2.84M

Avg: -

Company Overview

Metric
Company NameCelanese CorporationFMC Consulting
SymbolCE
MSH IDCOM:CELANESECOM:FMCES
MarketSTOCKSPRIVATE
SectorBasic MaterialsCommercial & Professional Services
IndustryChemicalsRecruitment & Staffing
CountryUSCN
Stage
Employee Count12.40K
Websitecelanese.comfmces.com
LinkedIncelanese
Founders

Market Metrics

Metric
Market Cap14.71B
Enterprise Value
Monthly Web Traffic31.83K
Web Traffic Growth8.85
Valuation
Raised Capital

Financial Performance

Metric
Revenue10.94B
Revenue (LTM)
Revenue (NTM)
Gross Profit2.43B
EBITDA1.92B
Operating Income1.21B
Net Income1.96B
EPS18.01
Diluted EPS17.92
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.24
Operating Profit Margin0.16
EBITDA Margin0.18
Net Profit Margin0.19
Return on Equity0.32
Return on Assets0.08
Return on Capital Employed0.08

Valuation Multiples

Metric
P/E Ratio7.77
P/B Ratio2.43
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.71
EV Multiple4.78

Operational Metrics

Metric
Days Sales Outstanding65.00
Days Payables Outstanding55.24
Days Inventory Outstanding110.45
Operating Cycle177.05
Cash Conversion Cycle149.12
Asset Turnover0.41

Cash Flow Metrics

Metric
Operating Cash Flow1.90B
Free Cash Flow1.33B
Cash Flow to Debt0.15
Operating Cash Flow/Sales0.20
Free Cash Flow Yield0.07

Balance Sheet Metrics

Metric
Cash & Equivalents1.80B
Accounts Receivable105M
Inventory2.36B
Goodwill6.98B
Debt to Capitalization0.66
Debt to Assets0.55
Current Ratio1.63
Quick Ratio0.88

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.00
R&D to Revenue0.01
SG&A to Revenue0.02